Left ventricular reconstruction: Early and late results  by Mickleborough, Lynda L. et al.
Surgery for
Acquired
Cardiovascular
Disease
Left ventricular reconstruction: Early and late results
Lynda L. Mickleborough, MD
Naeem Merchant, MD
Joan Ivanov, PhD
Vivek Rao, MD
Susan Carson, AHT
Dr Mickleborough
See related editorial on page 21.
Objectives: In patients with coronary disease and poor left ventricular function,
ventricular reconstruction with revascularization is a surgical option. Details of
patient selection and optimal surgical technique are still debated. This study reports
results achieved with ventricular reconstruction in 285 patients who had akinesia or
dyskinesia associated with relative wall thinning.
Methods: Data were prospectively collected. Reconstruction on the beating heart was
accomplished by a modified linear closure plus septoplasty, when indicated, (dys-
kinetic septum). Preoperatively, 237 (83%) were in symptom class III or IV with
congestive heart failure (n 174; 61%), angina (n  157; 55%), or ventricular tachy-
cardia (n  107; 38%). Average ejection fraction was 24%  11%, and 144 (51%)
had preoperative grade 2 mitral regurgitation. Operative procedures included
coronary artery bypass grafting in 262 (92%), septoplasty in 64 (22%), ablation of
ventricular tachycardia in 118 (41%), and a mitral valve procedure in 6 (2%).
Results: Operating room mortality was 2.8%. Perioperative support included intra-
aortic balloon pumping in 49 (17%) and inotropic drugs in 154 (54%). During a
mean follow-up of 63  48 months, 8 patients required transplantation (interval of
49  41 months), 2 needed mitral valve replacement, and 9 required use of an
implantable cardioverter-defibrillator for ventricular tachycardia. At 1, 5, and 10
years actuarial survivals were 92%, 82%, and 62%. Freedom from sudden death was
99%, 97%, and 94%. Among survivors, symptom class improved in 140 of 208
patients (67%), mean improvement 1.3  1.1 functional class per patient. Average
increase in ejection fraction postoperatively was 10%  9%.
Conclusions: Using wall thinning as a criterion for patient selection, left ventricular
reconstruction can be performed with low operative mortality, provides good
control of symptoms, excellent long-term survival, and freedom from sudden death.
This approach should be considered in all patients with coronary disease, poor left
ventricular function, and relative wall thinning.
Treatment of ischemic heart disease continues to be a challenge withmore patients presenting with congestive heart failure. In patientswith coronary disease and a previous infarct, the goal of surgeryshould be not only to prevent ongoing ischemia, but also to minimizethe negative effects of the infarct on ventricular structure and func-tion. After infarction, necrotic muscle is replaced by fibrous tissue.
When significant scarring occurs, an area of relative thinning often results along the
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distribution of the infarct vessel (elliptical in shape). The
amount of thinning and compensatory ventricular dilatation
that occurs is highly variable.
For many years, left ventricular (LV) aneurysm resection
has been recommended in patients with coronary disease as
a treatment for heart failure, angina, and thromboembolic
complications or to control ventricular arrhythmias. The
original procedure as applied to discrete dyskinetic aneu-
rysms included excision of the thin-walled sac, leaving
behind a rim of scar to facilitate closure, which was accom-
plished in a linear fashion. Technical modifications have
been advocated including the purse-string technique of
Jatene,1 the endoaneurysmorrhaphy technique originally de-
scribed by Cooley,2 and the endoventricular circuloplasty of
Dor and coworkers.3 Recently, these techniques have been
applied in patients without a discrete aneurysm (ventricular
reconstruction) as a treatment for ischemic cardiomyopa-
thy.4-6
In the 1980s we began resecting areas of scar mixed with
viable muscle in patients with ventricular arrhythmias.
These areas were thinner than normal but were not classic
aneurysms as described in the literature. By resecting these
portions of the wall we could approach arrhythmogenic
sites, which almost always corresponded to areas of septal
scarring. The repair involved patch exclusion of any aneu-
rysmal portion of the septum. Encouraged by our results in
1994, we advocated a liberal approach to ventricular recon-
struction.7 Goals are to resect or exclude thinned, nonfunc-
tioning parts of the ventricle and to restore size and shape
toward normal as much as possible. We described this new
technique, which combines patch septoplasty, when indi-
cated, with a modified linear closure and recommended it
for use in patients with akinetic or dyskinetic scar.8 This
article updates our experience and describes results
achieved. Whether the procedure is called aneurysm resec-
tion, heart reduction surgery, ventricular surgical remodel-
ing, or restoration, the principles are the same. We have
used preoperative and postoperative multiple gated acquisi-
tion (MUGA), echocardiography and more recently mag-
netic resonance imaging (MRI) to provide objective evi-
dence of improvement in ventricular and mitral valve
function.
Methods
Between 1983 and 2002, 285 consecutive patients underwent
ventricular reconstruction by a single surgeon (L.M.). In 3 cases
with extensive calcification, a free wall patch was needed to
achieve closure without distorting the ventricular chamber. These
cases have been excluded from this series. In 282 patients tailored
wall excision and septoplasty, when indicated, was followed by a
modified linear closure. Patients were selected for the operation.
Those with right ventricular (RV) hypokinesis or severe pulmo-
nary hypertension (pulmonary artery pressures at the systemic
level) and those with diffuse disease in all coronary distributions
were considered inoperable. Until recently, associated severe mi-
tral regurgitation (MR) was considered a relative contraindication.
On ventriculography, gross chamber dilatation or extensive wall
motion abnormalities were not considered a contraindication so
long as reasonable contractile function was preserved in some
portion of the ventricle. Since 1988, detailed wall motion analysis
was possible in 161 patients by a center-line method.9 The extent
of asynergy was calculated as a percentage length of the LV
perimeter showing a fractional shortening below 2 SDs from
normal mean values.9 Angiography provides no information with
regard to extent or distribution of wall scarring and thinning. In
dilated poorly functioning hearts, it was often difficult to accu-
rately assess size and function at the apex by 2D echocardio-
graphic techniques. In the past we have used needle aspiration to
evaluate wall thinning intraoperatively.8 Since 1998 we have used
MRI to preoperatively assess ventricular shape, volume, regional
wall motion, and thinning. This allowed us to decide whether a
patient with poor LV function was a candidate for revasculariza-
tion alone (no thinning) or in combination with surgical recon-
struction. Some evaluation of ventricular size was possible in 234
of 253 anterior scars (92%): echocardiographic end-diastolic di-
mension was used in 158 (62%), ventriculographic analysis in 179
(71%), or MRI in 41 (16%). Preoperative and postoperative MRI
data were used to evaluate changes in volume and shape by the
eccentricity index.10
Operative Procedure
Our operative procedure, which includes tailored scar excision,
septoplasty, when indicated, and modified linear closure, has been
described.8 We use MRI or needle aspiration to determine whether
akinesis or dyskinesis in the free wall corresponds to an area of
hibernating myocardium that may benefit from revascularization
or to an area of scarred, thinned wall that should be resected. Once
thinning is established, a small incision is made and any clot
present is removed. Only then is a vent inserted. With the unloaded
heart open and beating, the surrounding wall is palpated and its
ability to contract (regional wall thickening) assessed. All thinned,
nonfunctioning portions are considered for resection. The size and
shape of the cavity that will be left behind can be evaluated.
Excision is planned to remove as much nonfunctioning wall as
possible and to restore ventricular size and shape toward normal by
the modified linear closure.8 One can avoid creating too small a
chamber by preserving or reestablishing normal spatial relation-
ships between the papillary muscle insertions and the septum.
In patients with significant septal scarring, a visually directed
endocardial excision and cryoablation at the periphery is carried
out.11 When part of the septum is aneurysmal (clearly bulging into
the RV), a patch septoplasty is performed. This excludes the
aneurysmal septum from the remaining LV cavity, as shown in
Figure 1. The anterior edge of the patch is incorporated into the
modified linear closure as previously described.8 Length of the
closure is plicated in the repair. In this manner the LV “apex” is
recreated adjacent to the RV apex and ventricular shape is restored
toward normal (Figures 1 and 2). After repair, revascularization is
carried out with a graft to the proximal left anterior descending
coronary artery whenever possible. We use retrograde cardioplegia
to protect the LV and antegrade cardioplegia or infusion down a
right graft to protect the RV.
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Follow-up
Follow-up was completed in 2002 by telephone contact with the
patient or the referring physician. Preoperative and postoperative
studies were done by MUGA in 228 (89%) to assess LV ejection
fraction (LVEF), by echocardiography in 203 (71%) to assess MR,
and by MRI in 29 (10%) to assess ventricular volume and shape.
Statistical Analysis
The SAS (SAS Institute, Inc, Cary, NC) and BMDP (BMDP
Software, Los Angeles, Calif) programs were used for statistical
analysis. Patient characteristics were compared by means of the t
test for continuous variables and the 2 or Fisher exact test for
categorical variables. Results are presented as mean  SD in the
text and tables and mean  SE in the figures. Actuarial survival
was calculated by the Kaplan-Meier statistic. A Wilcoxon test was
used to evaluate differences in survival among patient subgroups.
A good long-term result, defined as 5-year survival without the
need for transplantation or repeated hospitalizations (more than
one) for heart failure was evaluated multivariately by a Cox
proportional hazards model with the following building strategy.
Variables with a univariate P value of less than .25 or those of
known biologic importance but failing to meet the critical  level
were submitted for consideration to the multivariate analysis by
stepwise selection.
Results
Patient Population
Subgroup characteristics—anterior compared with posterior
and akinetic compared with dyskinetic—are listed in Ap-
pendix 1. There were 285 patients whose ages ranged from
22 to 78 years (mean, 60 10 years). There were 38 female
patients (17%). Mean delay from infarct to repair was 54 
71 months (median 12 months). Resection was anterior in
253 (89%) and posterior in 32 (11%). Major indications for
surgery were often multiple and included class III or IV
congestive heart failure, 174 (61%); class III or IV angina,
157 (55%); ventricular tachycardia, 108 (38%); and embo-
lism, 6 (2%). Most patients (n  237, 83%) were in symp-
tom class III or IV (angina, congestive heart failure, or
both). Double or triple vessel disease was present in 239
(84%). The distribution of preoperative EF is shown in
Figure 3. Two hundred sixty-eight patients (94%) had an EF
less than 40% (mean, 24%  11%). Of patients analyzed,
97 (60%) had akinesia and 64 (40%) had dyskinesia. Mean
asynergy was 54%  15% for dyskinetic scar and 54% 
18% for akinetic scar. Ventricular volume was grossly en-
larged (end-diastolic dimension greater than 63 mm or
end-diastolic volume index (EDVI) greater than 100 mL/
m2) in 101 of 253 patients (40%).
At operation, associated procedures included clot re-
moval in 73 (26%), patch septoplasty in 64 (22%), arrhyth-
mia ablation in 118 (41%), mitral valve replacement in 3
(1%), mitral annuloplasty in 3 (1%), and coronary artery
bypass grafting in 264 (93%), with an average of 3.0  1.0
grafts per patient. In 19 (7%) the entire procedure was
carried out on the beating heart. In 266 the average cross-
clamp time was only 63  25 minutes. Average pump time
was 171  52 minutes. All patients were successfully
weaned from bypass, but 141 (50%) required inotropic
support and 49 (17%) required an intra-aortic balloon pump.
There were 8 hospital deaths (mortality 2.8%). Two were
related to adult respiratory distress syndrome in patients
receiving amiodarone. Six were related to congestive heart
failure and ventricular arrhythmias. Five patients (1.8%)
had perioperative infarcts. Eight patients (3%) required re-
operation for bleeding. There were 3 (1%) sternal infec-
tions, 2 (0.7%) transient ischemic attacks, and 1 (0.4%)
stroke.
During follow-up, which extends to 19 years (mean, 63
 48 months), there were 69 late deaths: congestive heart
failure, 39; sudden death, 8; ventricular arrhythmias, 1;
stroke, 1; renal failure, 3; myocardial infarction; 4; chronic
obstructive pulmonary disease, 1; brain aneurysm, 1; and
cancer, 6. Two patients died after a subsequent transplant
and 1 patient died after a subsequent mitral valve replace-
ment. The cause of death was unknown in 2 patients.
The actuarial survival curves (including hospital deaths)
for the entire population and various subgroups are shown
in Figure 4. Overall survival was 92% at 1 year, 82% at 5
years, and 62% at 10 years. Among survivors, 7 patients
required cardiac transplantation (mean interval 48  40
months). Two required mitral valve replacement, 18 re-
quired a pacemaker for bradyarrhythmias, and 9 received an
implantable cardioverter-defibrillator. Excluding patients
receiving a defibrillator, freedom from sudden death or
recurrent ventricular tachycardia was 99%, 97%, and 94%
at 1, 5, and 10 years.
Figure 1. Technique of septal aneurysm patch exclusion. A, Api-
cal aneurysm with significant thinning and aneurysmal involve-
ment of distal septum. B, Pericardial patch sewn to the preserved
normal portion of the septum on three sides. The anterior edge of
the patch is pulled tight and incorporated into the anterior mod-
ified linear closure as indicated by the arrows. C, The patch
effectively excludes the aneurysmal portion of the septum from
the residual LV cavity and helps restore more normal conical
shape of the ventricle. (Reprinted from Mickleborough LL, Mer-
chant N, Provost Y, Carson S, Ivanov J. Ventricular reconstruction
for ischemic cardiomyopathy. Ann Thorac Surg. 2003;75:S6-12;
published with permission.)
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According to multivariable analysis (Table 1), predictors
of poor 5-year result included EF less than 20%, congestive
heart failure, preoperative ventricular tachycardia, and a
history of hypertension. Poor outcome was not related to
age, sex, extent of coronary disease, MR, presence or ab-
sence of septoplasty, crossclamp time, or pump time. Be-
cause assessment of wall motion and ventricular volume
was not available in all patients, we could not enter these
variables into the model. However, at 5 years 26 of 78
patients (33%) with a grossly enlarged heart had poor re-
sults versus 11 of 59 (19%) with a small heart (P  .080).
Of patients with dyskinesis, 7 of 39 (18%) had a poor 5-year
result versus 18 of 66 (27%) of those with akinesis (P 
.347).
Among survivors, 140 of 208 (67%) were symptomati-
cally improved, 76 (37%) symptom class I and 60 (29%)
symptom class II. Average increase in symptom class was
1.3  1.1 classes per patient (P  .000). Preoperative and
postoperative MUGA or MRI assessment was available in
178 of the patients with an anterior aneurysm. There was a
statistically significant increase in EF (paired t test), with a
mean change of 10%  9% (P  .000). MRI in 41 patients
revealed a mean preoperative EDVI of 133  52 mL/m2
and a mean end-systolic volume index (ESVI) of 97  49
mL/m2. Postoperative mean EDVI was 103  35 mL/m2
and mean ESVI 65  31 mL/m2, mean change EDVI 29 
37 mL/m2 and ESVI 32  39 mL/m2 (P  .000). The mean
diastolic eccentricity index was 0.78  0.06 preoperatively
versus 0.74  0.11 postoperatively (P  .039). Average
systolic eccentricity index was 0.83  0.06 preoperatively
versus 0.81 0.07 postoperatively (P .118). Preoperative
and postoperative echocardiograms were performed in 203
patients. Of these 129 (64%) had grade 2 or more MR
preoperatively. In 74 of 129 (57%) the MR was improved
by at least 1 grade postoperatively.
Discussion
This article updates results achieved in a large series of
patients with akinetic or dyskinetic areas of relative wall
thinning in whom ventricular reconstruction was accom-
plished by a modified linear closure technique. Patch sep-
toplasty is an important part of the procedure when a portion
of the septum is aneurysmal. A knowledge of normal ven-
tricular size and geometry is essential before using this
technique. Wall excision is tailored to preserve or reestab-
lish the normal spatial relationships between papillary mus-
cle insertion sites and the septum and to restore cavity size
and shape as much toward normal as possible. This avoids
creating too small a cavity with the repair. We believe, as
does Jatene,1 that completing the repair on the beating heart
has the advantages of minimizing the ischemic time and
Figure 2. Preoperative (left) and postoperative magnetic resonance imaging. Preoperatively, an anteroapical
aneurysm involves the distal portion of the septum; the apex is globular in shape. Postoperatively, a septal patch
has excluded the aneurysmal septum and is incorporated anteriorly into the modified linear closure. The space
between the patch and septal aneurysm has been filled with clot. Ventricular volume is decreased and the shape
of the apex has been restored toward normal; namely, it is more conical. (Reprinted from Mickleborough LL,
Merchant N, Provost Y, Carson S, Ivanov J. Ventricular reconstruction for ischemic cardiomyopathy. Ann Thorac
Surg. 2003;75:S6-12; published with permission.)
Figure 3. Histogram showing distribution of preoperative LVEF
among our patient population.
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facilitating decision making with regard to optimal restora-
tion of LV geometry and size. In the beating ventricle it is
easy to assess local wall function by palpation. We have not
found an intraventricular balloon to be helpful, although its
use has been recommended by centers performing recon-
struction in an arrested heart.4 We agree with Suma and
associates12 that in akinetic aneurysms the limits of scarring
are not always well demarcated, nor is the extent of endo-
cardial scar a reliable indicator of the border between func-
tioning and nonfunctioning wall. With alternative repair
techniques it may be difficult, in some cases, to determine
the exact size and location of patch to be used. Recently,
Menicanti and Di Donato13 described a modification of the
Dor procedure, for use in large apical aneurysms, that
involves plication of the distal inferior wall before patch
placement. Our approach in such cases is to patch the
aneurysmal septum and extend the free wall excision over
the apex. After removal of the thinned nonfunctioning wall,
the length of the residual opening (elliptical in shape) is
plicated by placing mattress suture bites wider on the tissue
edges than on the felt strips. Completion of the repair
locates the new “apex” of the LV next to the RV apex and
the conical shape of the LV is restored (Figures 2 and 3).
We also tailor the excision and suture line to leave the left
anterior descending coronary artery for revascularization.
Septal branches may provide collaterals for effective deliv-
Figure 4. Actuarial survival after ventricular reconstruction for overall population and for subgroups with and
without congestive heart failure (CHF), ventricular arrhythmias (VT), hypertension, or EF less than 20%. Asterisks
(*) indicate a statistically significant difference between curves as determined by the log-rank test (P < .05).
Figures in parentheses at the bottom indicate number of patients left at risk at that time of follow-up.
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ery of retrograde cardioplegia, and revascularization of even
a small portion of the septum may help improve short- and
long-term results.14,15
We do not perform ventricular reconstruction in patients
whose wall motion abnormalities occur in areas of relatively
normal wall thickness. We prefer to revascularize these
areas and have achieved good results with this approach,
even in patients with severely depressed ventricular func-
tion (EF  20%).16
This series includes patients with a variable extent of
akinetic and dyskinetic scar in both anterior and posterior
locations. A high proportion of patients had multivessel
coronary disease, advanced LV dysfunction, and ventricular
arrhythmias, factors found in other series to be related to
increased operating room mortality.4,5,13,14,17 Nevertheless
our hospital mortality was low, 2.8% compared with those
in other series, which range from 7% to 13%.4,6,13,14
Clearly, case selection and operative technique may account
for these differences.
After ventricular reconstruction, close follow-up and ad-
justment of medications is necessary to optimize results.
During follow-up, 13 patients underwent additional proce-
dures for increasing heart failure, including 8 transplants
and 2 mitral valve replacements. Five-year survival was
82%, which can be compared with survival in other reported
series at 2 years, 82% to 86%,6,18 and at 5 years, 58% to
70%.5,14,17,19
We defined poor 5-year result as the need for transplan-
tation or repeated hospitalization for congestive heart fail-
ure. Multivariable predictors of poor 5-year outcome were
EF less than 20%, congestive heart failure, ventricular
tachycardia, and hypertension (Table 1). In patients with
volume data, marked ventricular enlargement also predicted
poor outcome: a poor result was obtained in 21 of 78 (33%)
with a large heart versus 11 of 59 (19%) with a small heart
(P  .080). Similar relationships between heart failure,
decreased EF, increased ventricular size, and poor long-
term result have been reported by others.4,5,13,17
In this series, objective evidence of improved LV func-
tion after the operation was provided by MUGA or MRI
data. The average increase in EF of 10%  9% (P  .000)
is similar to that of 10% to 14% reported in other se-
ries.4,6,13,14 Unfortunately, reliable postoperative informa-
tion regarding volume and shape was only available with
the use of MRI in a small subgroup. Postoperatively, the
mean EDVI decreased by 30  38 mL/m2 (P  .000) and
mean ESVI decreased by 32 39 mL/m2 (P .000). These
values are similar to those reported by Athanasuleas for the
RESTORE Group.4
In prior reports, operative mortality was increased in
patients with akinesis versus dyskinesis, and it has been
suggested that patients with akinesis benefit less in terms of
symptom relief, improvement in EF, and long-term surviv-
al.20,21 In this series there was no difference between aki-
netic and dyskinetic groups with respect to patient charac-
teristics including time delay between infarct and repair.
Five patients in the akinetic group died in the hospital, with
no deaths in the dyskinetic group (P  .158). There was no
difference in the need for inotropic drugs or intra-aortic
balloon pumping. Among survivors, more patients in the
akinetic group had improved symptoms: 58 of 69 (84%)
versus 35 of 53 (66%) P .031; however, the postoperative
change in EF (10%  11% versus 10%  10% [P  .953])
and 5-year survival were similar: 89% versus 78% (P 
.168). Dor and associates9 also showed no difference be-
tween the 2 groups.
This report includes 32 patients with posterior repair.
Compared with the anterior group, these patients were
older, had angina less often, smaller areas of abnormal wall
motion as defined by percent asynergy, and better preoper-
ative EF (Appendix 1). At surgery, only 1 posterior recon-
struction involved a patch septoplasty but in 4 (13%), a
small pericardial patch was used adjacent to the mitral
annulus to reinforce the linear closure as previously de-
scribed.8 This group had more valve interventions than the
anterior group: 3 of 37 (9%) versus 3 of 253 (1%) (P 
.020). Tavakoli and associates22 reported worse results with
posterior repairs. In our series all patients with posterior
repair survived and had similar improvement in symptom
class and change in EF compared with anterior repairs.
Long-term survival was excellent: 97%, 97%, and 90% at 1,
5, and 10 years (a difference that almost reached statistical
significance compared with the anterior group P  .059).
In considering patients for LV reconstruction the issue of
concomitant MR is important. Preoperative Doppler echo-
cardiography often indicates 2 MR when none was sus-
pected on the angiogram. Early in this series, we were
reluctant to add a valve intervention, and in 129 (45%)
patients with 2 MR or more, nothing was done to the
valve. In these cases we believed that LV reconstruction
would improve mitral valve function, which it did in 74
(57%); MR improved by at least 1 grade.23 Possible mech-
anisms for this improvement include (1) decreased annular
dilatation caused by decreased ventricular size, (2) im-
TABLE 1. Multivariable predictors of poor 5-year result by
means of Cox regression analysis in patients undergoing
ventricular reconstruction
Variable Risk ratio 95% CI 2 P value
EF 20% 2.12 1.3–3.5 8.6 .0034
CHF 2.07 1.3–3.4 8.1 .0045
VT 1.94 1.2–3.1 7.4 .0066
Hypertension 1.79 1.0–3.0 4.5 .0336
EF, Ejection fraction; CHF, congestive heart failure; VT, ventricular tachy-
cardia.
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proved papillary muscle function related to revasculariza-
tion, or (3) realignment of papillary muscles related to
improved geometry after repair. Recently we have replaced
the mitral valve in 3 patients with 4 MR. For those with
2 to 3 MR we have completed the ventricular recon-
struction and then reassessed MR with transesophageal
echocardiography. For persistent 3 MR we performed an
annuloplasty using an undersized ring as recommended by
Bolling and coworkers,24 or using a patch annuloplasty
technique that we described for posterior repairs.25 Whether
these interventions will further improve long-term results
needs to be assessed.
In ischemic cardiomyopathy, ventricular arrhythmias are
a major source of morbidity and mortality. The value of
revascularization in decreasing arrhythmia recurrence needs
to be stressed. The CABG Patch Trial showed that use of an
implantable cardioverter-defibrillator provided no addi-
tional benefit compared with revascularization alone with
respect to arrhythmia recurrence and long-term survival in
patients with poor EF (35%) and an abnormal signal
averaged electrocardiogram.26 When coronary artery bypass
grafting is combined with ventricular reconstruction, the
potential for controlling arrhythmias should be even greater.
Our experience using a mapping balloon in patients with
recurrent ventricular tachycardia demonstrated that ease of
arrhythmia induction was related to mechanical loading
conditions.10 Other investigators have confirmed that myo-
cardial stretch is arrhythmogenic.27 Therefore, any proce-
dure that restores ventricular volume and size toward nor-
mal (such as ventricular reconstruction) should help prevent
ventricular arrhythmias.
Mapping studies in patients with anteroapical scar
showed that the arrhythmia substrate was located in the
border zone between scar and normal endocardium on the
ventricular septum.28 In patients with septal scarring, we
performed a visually directed endocardial excision and pe-
ripheral cryoablation. Our series includes 108 patients with
preoperative ventricular tachycardia, which tended to occur
in dilated hearts: 45 of 101 (45%) with a large anterior scar
versus 23 of 101 (23%) with a small anterior scar, P .002.
Postoperatively, these patients had an electrophysiologic
study and those with inducible or spontaneous ventricular
tachycardia were discharged on amiodarone or received an
implantable cardioverter-defibrillator (n  9). Even though
ventricular tachycardia predicted a poor outcome at 5 years,
ventricular arrhythmias during follow-up were only rarely a
problem. Excluding patients receiving an implantable car-
dioverter-defibrillator, freedom from ventricular tachycar-
dia or sudden death was 99%, 97%, and 94% at 1, 5, and 10
years. These results can be compared with those of Wellens
and associates,29 who used a visually directed ablation
procedure to achieve at 4 years an 84% freedom from
ventricular tachycardia and a 57% survival. The combina-
tion of revascularization, LV reconstruction, and visually
directed ventricular tachycardia ablation appears to be very
effective in preventing arrhythmias.
Recently, Buckberg,30 has proposed that in patients with
ischemic cardiomyopathy, ventricular shape may have an
important influence on function and prognosis. In our ex-
perience, postoperative MRI has shown return of shape
toward normal (Figures 2 and 5), yet the mean diastolic
eccentricity index (which is supposed to reflect shape
change and which would be expected to increase postoper-
atively) actually decreased 0.78  0.06 versus 0.74  0.11,
P  .039. Dor has reported similar results; mean preoper-
ative diastolic eccentricity index 0.70  0.09 decreased
Figure 5. Preoperative (left) and postoperative magnetic resonance imaging. Preoperatively, an anteroapical
infarct has resulted in thinning of the distal septum. The distal portion of the ventricle is globular in shape. After
repair with a septal patch, there is restoration of a more normal conical shape to the ventricle.
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postoperatively to 0.44  0.18. This seems counterintuitive
and requires some explanation. Ventricular shape in these
patients is asymmetric, and after anteroapical infarction the
major shape change occurs in the distal third to half of the
ventricle. Standard measures used to assess shape change,
the sphericity index or eccentricity index, are based on two
end-diastolic dimensions, the long axis and the short axis
diameter at the upper third of the ventricle. With progressive
adverse remodeling, the magnitude of change in the short
axis diameter depends on size, location, and compliance of
the infarct and whether or not there is associated MR. For
example, 1 patient in this series had an EDVI of 289 mL/m2
and an ESVI of 259 mL/m2, yet the short axis diameter was
only 54 mm in diastole and 41 mm in systole. We believe
that in such patients the shape should be evaluated in a way
that draws attention to the distal half of the ventricle, where
the major shape changes occur. This would be particularly
appropriate in attempting to compare results achieved with
different surgical repair techniques.
Limitations of the Study
In this single center study, we used specific selection criteria
to choose patients for LV reconstruction including the re-
quirement for relative wall thinning. Whether application of
the patch exclusion technique as recommended by the RE-
STORE Group to exclude akinetic areas of normal thickness
will lead to better results than those currently achieved in
such patients with revascularization alone, remains to be
seen. Another limitation of this series is the lack of postop-
erative studies in most patients, which are needed for de-
tailed analysis of changes in ventricular volume and shape
after repair. Nevertheless, the available MRI data showed
significant changes in ESVI, which are comparable with
those reported by the RESTORE Group (mean decrease in
ESVI 32  39 mL/m2 versus 34  42 mL/m2).4 Further
follow-up will be needed to relate the observed changes in
volume and shape to long term outcome.
On the basis of our results, we recommend an aggressive
approach to revascularization and ventricular reconstruction
in patients with coronary disease and poor LV function. We
believe that areas of akinesis or dyskinesis associated with
relative thinning should be excised to restore ventricular
size and shape toward normal and to prevent progressive
adverse remodeling. If repair is delayed, contractile function
of the residual viable muscle may deteriorate with decrease
in EF, increase in wall stress, and chamber dilatation, which
may be associated with a less satisfactory surgical result.13
Like Dor9 and Di Donato and Menicanti,13 we recom-
mend early repair because surgical risk in these patients is
low. We suggest that patients with akinesis or dyskinesis
should be observed closely and considered for surgical
treatment when signs of decompensation first occur, such as
increasing symptoms with optimal medical management or
in asymptomatic patients if there is evidence of increasing
ventricular volume or MR. Surgery should be considered
before these patients reach the stage when transplantation is
the only reasonable option. As this series demonstrates, in
selected patients ventricular reconstruction by a modified
linear closure technique plus patch septoplasty, when indi-
cated, can be done in the beating heart with low operative
mortality. The procedure provides good symptomatic im-
provement and excellent 5-year survival. The role of con-
comitant valve procedures in those with MR requires further
investigation.
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Discussion
Dr Lorenzo A. Menicanti (Segrate, Italy). This paper is an
excellent review of Dr Mickleborough’s personal experience. It
demonstrates the great benefits of volumetric reduction surgery
and confirms the results obtained by other surgical groups. We
completely agree with the general surgical philosophy presented in
this paper. There are several important questions that I would like
to discuss with the author, as well as the idea that these procedures
should be standardized as much as possible.
In your manuscript, you consider patients with severe pulmo-
nary hypertension, RV dysfunction, and diffuse disease of the
coronary arteries to be ineligible. These patients are in the worst
condition, with increased operative mortality, but the procedure
may be the only option they have, and probably we must give them
a chance. Can you define more precisely the dimensions of these
parameters?
The MR in your paper is a relative contraindication. You
present MR of more than 2 in 13% of the cases, but only 2% are
treated. Can you define your present strategy when 3 MR is
present or when MR is moderate but with an enlarged annulus?
Dealing with the surgical technique, in the RESTORE Group
experience, the results with the beating and the arrested heart were
compared but no differences were found. Do you think that this is
really important in the procedure? In my understanding, the beat-
ing heart technique can be harmful when a recent infarction is
treated and the tissues are fragile or when the mitral valve is
approached.
The septoplasty in your presentation was performed in 22% of
the cases. How do you judge the septal involvement before going
into the operating room?
Some authors demonstrate that excessive reduction of the lon-
gitudinal diameter can result in diastolic dysfunction of the LV.
Therefore, preserving the normal relationship between longitudinal
and transverse diameter can be of importance. How do you treat
the ventricle that has a transitional zone at the base of the papillary
muscle involving the inferior wall to avoid a spherical cavity?
In your paper you said that excision is planned to remove as
much nonfunctioning wall as possible. The risk is that too small a
cavity will be created. Do you have some guideline to avoid this
complication?
Your experience covered a period of 20 years. Did you notice
any differences in patients’ characteristics in the most recent
period when primary angioplasty and thrombolysis are so fre-
quent?
Finally, did the introduction of MRI change in some way your
strategy or your results?
Dr Mickleborough. Thank you, Dr Menicanti, for those kind
remarks. You and Dr Dor have a similar experience using slightly
different techniques, but I believe that our philosophy overlaps
greatly. I will try to answer all of your questions.
As far as patient selection is concerned, if a patient’s pulmo-
nary artery pressures are systemic or near systemic, I am not as
brave as you are: I cannot get such patients through this operation.
I would consider patients with severe RV failure with recurrent
hepatic congestion or coagulopathy to be inoperable with this
approach.
Diffuse coronary artery disease is a very relative thing. Many
patients in this series had nonvisualized vessels, but about 90% of
the time, even when a vessel is completely nonvisualized, when
you explore the area you will find something you can graft. When
I refer to inoperable coronary disease, I am talking about patients
whose vessels you can see, but they are moth-eaten all the way
down. There is no good place to do a graft, and all three distribu-
tions are affected. I consider such patients with nongraftable cor-
onary artery disease and very poor ventricular function too much
of a challenge and inoperable.
With respect to MR, when I started doing this in the 1980s, I
was very reluctant to do a mitral valve procedure in addition to
map-guided ablation of ventricular tachycardia, LV reconstruction,
and bypass surgery. In the past 10 years I have become much more
willing to take on patients with 4 MR or 3 MR, and at the
present time my recommendation would be that anyone who has
3 or 4 MR needs a valve procedure. In my hands, if they have
4 MR they get a valve replacement, and if they have 3 MR, I
will do a valvuloplasty. If they have 2 MR going into the
procedure, I will do my reconstruction and then do a transesoph-
ageal intraoperative assessment. In the past, we have not had a
patient in whom the MR has gotten worse, but if that should
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happen and the MR was then 3, I would go back and do a
valvuloplasty. I do not think these patients should be left with 3
MR.
Do I think the beating heart is important? That ties in with
another of your questions about how to maintain ventricular vol-
ume after the repair. Nature is a wonderful thing. When we are
referred patients with a prior myocardial infarction, nature has
already selected who will survive and who will not. If a patient
makes it to our operating room, God has been generous to him or
her and has left enough functioning ventricle behind so that if I do
not make a mistake and get too greedy with my resection, the
patient will not end up with too small a cavity. In my experience,
the location of the papillary muscles is a very useful guide. In
doing the resection, stay away from the base of the papillary
muscles. Leave a little bit of thin wall in, if you have to. Do not
involve the papillary muscles in the resection, because if you start
relocating the papillary muscles in these types of patients, you may
very well end up with too small a cavity.
In determining the limits of the resection, as in valve surgery,
experience counts and the decision should be based on your gestalt
of the situation. To make these decisions, there is no “correct”
formula. Your group uses a balloon, which may be an excellent
device. I do not find it helpful, because in the beating heart, the
balloon will not stay where I want it anyway. So I use my
experience and visual assessment to ensure an adequate size in the
cavity that will result from the repair.
With respect to the septum, before I had MRI, I had to rely on
visual assessment at the time of the operation. When you open up
such a heart and look at the septum, you can tell whether it is just
scarred or whether it is scarred and bowed into the RV cavity. In
the latter case, you need to do a septoplasty. MRI is a wonderful
technique, and with it you can tell ahead of time exactly which
patient has a thinned aneurysmal septum and needs to have a
septoplasty and which patient does not.
As far as the short and long axis ratio is concerned, the
sphericity index is a very good index to assess symmetrical change
in ventricular shape, but it is terrible, in my opinion, for assessing
the changes that occur in these patients. With anteroapical infarcts,
most of the shape changes occur at the apex, not where the
papillary muscles insert and not where we measure short axis. I
think the sphericity index is the wrong index to be looking at when
judging shape change. Do I have a better one? Not yet, but I am
working on it.
This is only a 20-year experience, and we see fewer of the huge
dyskinetic anteroapical aneurysms than we used to. I think that is
because of better earlier intervention by our cardiology colleagues.
Dr Aubrey C. Galloway (New York, NY). Dr Mickleborough,
this is an excellent series and a group of patients whom everyone
will be seeing more frequently as our surgical population continues
to age and we operate on more patients with severely depressed
LV function.
As a follow-up on the earlier question related to concomitant
mitral valve repair, it appears that you recommended mitral repair
or replacement in patients with 3 or 4 MR, which is what we
would also advocate. Do you have any data that support this
recommendation? The recommendation certainly seems intuitively
obvious, based on other studies evaluating the impact of MR on
patients with poor ventricular function, showing that patients with
3 or 4MR have better survival and fewer symptoms if the MR
is corrected. In your series, did you see a progressive deterioration
in the patients with moderate MR in whom valve repair was not
performed?
Dr Mickleborough. That is a very good question. During
follow-up, there were 69 late deaths, and 39 of those deaths were
due to progressive congestive heart failure. Most of those patients
had progressive MR as part of the heart failure. Yes, I think this is
a very important issue.
We previously reported results achieved with revascularization
alone in patients with moderate MR. In those patients, the un-
treated valve did not seem to matter so long as ventricular function
was good. In other words, the patients who had 1 or 2MR and
had a grade 1 or 2 ventricle lived just as long as the ones who had
no MR. However, the subset that had grade 3 or 4 ventricles and
2 MR did not live nearly as long.
The ventricle will always be tied in with the mitral valve
apparatus and vice versa. I offer the following guidelines: In grade
3 or 4MR, something must be done, whether it is replacement
or repair. Grade 2MR should be reassessed after the reconstruc-
tion has been completed. If the regurgitation is the same or less, the
valve should be left alone and I think the 5-year survival will be
good. If it is worse, the valve should be fixed.
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Appendix 1. Patient subgroups
Anterior
(n  253) P
Posterior
(n  32)
Akinetic
(n  97) P
Dyskinetic
(n  64)
Preoperative clinical variables
Age (y) 60 10 .001* 66 7 61 9 .116 59 10
Male sex 212 (84%) .452 25 (78%) 79 (81%) .522 55 (86%)
Angina 145 (57%) .039* 12 (35%) 54 (56%) .418 40 (62%)
CHF 156 (62%) .569 18 (56%) 64 (66%) .408 38 (59%)
VT 91 (63%) .081 17 (53%) 32 (33%) 1.000 21 (33%)
Diabetes 38 (19%) 1.000 5 (17%) 76 (78%) .402 54 (84%)
Hypertension 95 (47%) .387 18 (57%) 50 (52%) .617 30 (47%)
PVD 20 (10%) .712 4 (13%) 13 (13%) .598 6 (9%)
Symptom class
I 8 (3%) .780 2 (6%) 2 (2%) .207 5 (8%)
II 34 (13%) 5 (16%) 14 (14%) 9 (14%)
III 85 (33%) 11 (34%) 38 (39%) 18 (28%)
IV 126 (50%) 14 (44%) 43 (44%) 32 (50%)
Interval from infarct (mo) 55 72 .408 43 59 58 75 .903 56 73
Catheterization data
Coronary disease
Single 40 (16%) .903 4 (13%) 14 (14%) .634 12 (19%)
Double 78 (31%) 11 (34%) 34 (35%) 19 (30%)
Triple 133 (53%) 17 (53%) 49 (51%) 33 (52%)
Ejection fraction
40% 13 (5%) .022* 4 (13%) 4 (4%) .257 6 (9%)
20%-40% 97 (38%) 19 (59%) 41 (42%) 22 (34%)
20% 143 (57%) 9 (29%) 52 (54%) 36 (56%)
Mean EF 27 10 .006* 30 12 28 9 .579 260 10
MR 2 or more 126 (44%) .113 18 (56%) 56 (58%) .488 39 (61%)
EDVI (mL/m2) 166 53 .913 165 50 166 57 .968 166 47
ESVI (mL/m2) 104 51 .993 104 38 102 52 .598 107 50
Asynergy (%) 54 17 .048* 46 21 54 18 .910 54 15
Intraoperative variables
Crossclamp time 62 23 .008* 74 33 60 24 .400 64 25
Pump time 171 51 .845 173 53 160 41 .200 169 47
CABG (%) 233 (92%) 29 (91%) 94 (97%) 59 (92%)
Average no. grafts 2.8 1.3 .688 2.7 1.2 3.0 1.2 .570 2.9 1.5
LITA use 127 (50%) .575 14 (44%) 62 (64%) .410 36 (56%)
VT ablation 110 (44%) .056 8 (25%) 36 (37%) .154 31 (48%)
Patch septoplasty 63 (25%) .003* 1 (3%) 30 (31%) .399 24 (38%)
Valve procedure 3 (1%) .020* 3 (9%) 2 (2%) .518 0
Results
Inotropic agents 128 (56%) .178 13 (41%) 51 (53%) .620 30 (47%)
IABP 46 (23%) .103 3 (9%) 18 (19%) .834 12 (19%)
Mortality 8 (3.2%) .604 0 5 (5%) .158 0
Improved symptoms 122/161 (76%) .472 18/26 (69%) 58/69 (84%) .031* 35/53 (66%)
Change in EF (%) 10 9 .186 6 16 10 10 .816 10 10
Good 5-y result 133/181 (74%) .031* 21/22 (96%) 48/66 (73%) .278 32/39 (83%)
CHF, Congestive heart failure; VT, ventricular tachycardia; PVD, peripheral vascular disease; EF, ejection fraction; EDVI, end-diastolic volume index; ESVI,
end-systolic volume index; CABG, coronary artery bypass grafting; LITA, left internal thoracic artery; IABP, intra-aortic balloon pump.
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